- 2023 - 2026 TRPV4の多面的作用に着目した多発性嚢胞腎病態に基づく疾患特異的治療の開発
- 2022 - 2025 CD4+CD28-T細胞を標的としたステロイド抵抗性慢性GVHDの治療開発
- 2021 - 2024 小児期シェーグレン症侯群におけるCD38による腺外組織障害への進展機序の解明
- 2020 - 2023 組織トランスグルタミナーゼに着目した多発性嚢胞腎病態に基づく疾患特異的治療の開発
- 2018 - 2022 Development of a new diagnostic method for pediatric HSPN using urinary biomarkers
- 2017 - 2020 Development of disease-specific therapy based on polycystic kidney disease pathophysiology focusing on lipid mediators
- 2017 - 2020 Elucidation of pathology and development of therapeutic agents in polycystic kidney disease focusing on Smad3 site-specific phosphorylation
- 2015 - 2019 Establishment of new diagnostic biomarker for childhood IgA nephropathy
- 2015 - 2018 Development of disease specific therapy based on pathophysiology of IgA nephropathy focusing on microRNA
- 2014 - 2017 Development of disease specific therapy based on microRNA in polycystic kidney disease
- 2012 - 2015 Role of imflammasome in IgA nephropathy
- 2011 - 2013 Disease specific therapy of polycystic kidney disease based on its pathophysiology considering the ubiquitin-proteasome proteolysis mechanism
- 2009 - 2011 Mutation analysis in Japanese patients with congenital and infantile nephritic syndrome
- 2008 - 2010 Epithelial-to-mesenchymal transition (EMT) in polycystic kidney disease
- 2006 - 2007 Genetic analysis of glomerular podocyte molecules in children with nephrotic syndrome
- 2005 - 2007 Analysis of NPHS1, NPHS2, ACTN4, WT1 and CD2AP in Japanese patients with congenital nephrotic syndrome
- 2003 - 2004 Genetic analysis in children with Escherichia coli O157-associated hemolytic uremic syndrome
- 2002 - 2004 Analysis of NPHS1, NPHS2, ACTN4 and WT1 in Japanese patients with congenital nephrotic syndrome
Show all
International Pediatric Nephrology Association
, The American Society of Nephrology
, International Society of Nephrology
, 日本小児腎不全学会
, 日本小児腎臓病学会
, 日本腎臓学会
, 日本小児科学会